<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0300-9041</journal-id>
<journal-title><![CDATA[Ginecología y obstetricia de México]]></journal-title>
<abbrev-journal-title><![CDATA[Ginecol. obstet. Méx.]]></abbrev-journal-title>
<issn>0300-9041</issn>
<publisher>
<publisher-name><![CDATA[Federación Mexicana de Colegios de Obstetricia y Ginecología A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0300-90412020000600385</article-id>
<article-id pub-id-type="doi">10.24245/gom.v88i6.3402</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Implicación del factor de necrosis tumoral alfa en el síndrome de ovario poliquístico]]></article-title>
<article-title xml:lang="en"><![CDATA[Involvement of TNF-alpha in the polycystic ovary syndrome]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Garza-Garza]]></surname>
<given-names><![CDATA[Mario Alberto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Delgadillo-Guzmán]]></surname>
<given-names><![CDATA[Dealmy]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Autónoma de Coahuila Facultad de Medicina UT ]]></institution>
<addr-line><![CDATA[Torreón Coahuila]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Autónoma de Coahuila Facultad de Medicina UT ]]></institution>
<addr-line><![CDATA[Torreón Coahuila]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2020</year>
</pub-date>
<volume>88</volume>
<numero>6</numero>
<fpage>385</fpage>
<lpage>393</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0300-90412020000600385&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0300-90412020000600385&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0300-90412020000600385&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  ANTECEDENTES: De 6 a 14% de las mujeres padecen síndrome de ovario poliquístico. En la práctica clínica este síndrome se subdianostica, circunstancia que deriva en complicaciones propias del padecimiento que incluyen: obesidad, resistencia a la insulina, alteraciones metabólicas e infertilidad. La fisiopatología no se ha definido por completo y en la actualidad se plantea la asociación de un proceso metabólico e inflamatorio crónico, donde las citocinas inflamatorias pueden tener alteraciones en su efecto y en su señalización.  OBJETIVO: Comunicar lo encontrado en una revisión sistemática actualizada de la implicación del factor de necrosis tumoral alfa en pacientes con síndrome de ovario poliquístico.  METODOLOGÍA: Revisión narrativa de artículos científicos indexados en Pub Med-NCBI, Web of Science, Google Scholar y Scopus, publicados en inglés o español entre 2014 y 2018 que en el título y resumen incluyeron los conceptos y asociación del síndrome de ovario poliquístico y del factor de necrosis tumoral alfa.  RESULTADOS: Se identificaron 43 artículos; luego de eliminar los duplicados quedaron 29 y, al final, la síntesis se efectuó con 11 artículos. Las publicaciones provinieron de distintos países: 54% de los estudios se efectuaron en Chile, Estados Unidos e Irán, proporcionalmente; el resto de los estudios se llevaron a cabo en Rusia, China, Korea, Egipto y Pakistán.  CONCLUSIONES: El factor de necrosis tumoral alfa es una citocina asociada con diferentes sistemas que tiene participación en el síndrome de ovario poliquístico.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  BACKGROUND: Polycystic ovary syndrome (PCOS) is a pathology present in 6 to 14% of women. However, in clinical practice it is underdiagnosed, which implies a presence of complications of the pathology that includes obesity, insulin resistance, metabolic alterations and infertility. The pathophysiology is not well defined, and the association of a chronic metabolic and inflammatory process is currently being considered, where inflammatory cytokines can present alterations both in their effect and in their signaling.  OBJETIVE: To present the results of an updated systematic review of the involvement of TNF-alpha in polycystic ovary syndrome.  METHODOLOGY:  Narrative revision of articles indexed in Pub Med-NCBI, Web of Science, Google Scholar and Scopus, published in English or Spanish between 2014 and 2018 that included the concepts and association of polycystic ovary syndrome and tumor necrosis factor alpha in the title and abstract.  RESULTS: 43 articles were identified; after eliminating the duplicates, 29 remained and, in the end, the synthesis was carried out with 11 articles. The publications came from different countries: 54% of the studies were carried out in Chile, the United States and Iran, proportionally; the rest of the studies were carried out in Russia, China, Korea, Egypt and Pakistan.  CONCLUSIONS: TNF-alpha is a cytokine associated with different systems that is involved in polycystic ovary syndrome.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Síndrome de ovario poliquístico]]></kwd>
<kwd lng="es"><![CDATA[obesidad]]></kwd>
<kwd lng="es"><![CDATA[resistencia a la insulina]]></kwd>
<kwd lng="es"><![CDATA[infertilidad]]></kwd>
<kwd lng="es"><![CDATA[citocinas]]></kwd>
<kwd lng="es"><![CDATA[factor de necrosis tumoral alfa]]></kwd>
<kwd lng="es"><![CDATA[bibliométricos]]></kwd>
<kwd lng="en"><![CDATA[Polycystic Ovary Syndrome]]></kwd>
<kwd lng="en"><![CDATA[Obesity]]></kwd>
<kwd lng="en"><![CDATA[Insulin Resistance]]></kwd>
<kwd lng="en"><![CDATA[Infertility]]></kwd>
<kwd lng="en"><![CDATA[Cytokines]]></kwd>
<kwd lng="en"><![CDATA[TNF-alpha]]></kwd>
<kwd lng="en"><![CDATA[Bibliometrics]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Evans]]></surname>
<given-names><![CDATA[TN]]></given-names>
</name>
<name>
<surname><![CDATA[Riley]]></surname>
<given-names><![CDATA[GM.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Polycystic ovarian disease (Stein-Leventhal syndrome); etiology and rationale for surgical treatment]]></article-title>
<source><![CDATA[Obstet Gynecol]]></source>
<year>1958</year>
<volume>12</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>168-79</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dumesic]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome]]></article-title>
<source><![CDATA[Endocr Rev]]></source>
<year>2015</year>
<volume>36</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>487-525</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ehrmann]]></surname>
<given-names><![CDATA[DA.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Polycystic ovary syndrome]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2005</year>
<volume>352</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1223-36</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moran]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence of polycystic ovary syndrome and related disorders in mexican women]]></article-title>
<source><![CDATA[Gynecol Obstet Invest]]></source>
<year>2010</year>
<volume>69</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>274-80</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cadagan]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Thecal cell sensitivity to luteinizing hormone and insulin in polycystic ovarian syndrome]]></article-title>
<source><![CDATA[Reprod Biol]]></source>
<year>2016</year>
<volume>16</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>53-60</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Teede]]></surname>
<given-names><![CDATA[HJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome]]></article-title>
<source><![CDATA[Clin Endocrinol (Oxf)]]></source>
<year>2018</year>
<volume>89</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>251-68</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rotterdam]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome]]></article-title>
<source><![CDATA[Fertil Steril]]></source>
<year>2004</year>
<volume>81</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>19-25</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dunaif]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis]]></article-title>
<source><![CDATA[Endocr Rev]]></source>
<year>1997</year>
<volume>18</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>774-800</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[El Hayek]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Polycystic ovarian syndrome: An updated overview]]></article-title>
<source><![CDATA[Front Physiol]]></source>
<year>2016</year>
<volume>7</volume>
<numero>124</numero>
<issue>124</issue>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rosenfield]]></surname>
<given-names><![CDATA[RL.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The diagnosis of polycystic ovary syndrome in adolescents]]></article-title>
<source><![CDATA[Pediatrics]]></source>
<year>2015</year>
<volume>136</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1154-65</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rosenfield]]></surname>
<given-names><![CDATA[RL.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The polycystic ovary morphology-polycystic ovary syndrome spectrum]]></article-title>
<source><![CDATA[J Pediatr Adolesc Gynecol]]></source>
<year>2015</year>
<volume>28</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>412-9</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Goodman]]></surname>
<given-names><![CDATA[NF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guide to the best practices in the evaluation and treatment of polycystic ovary syndrome]]></article-title>
<source><![CDATA[Endocr Pract]]></source>
<year>2015</year>
<volume>21</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1291-300</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kelly]]></surname>
<given-names><![CDATA[CC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Low grade chronic inflammation in women with polycystic ovarian syndrome]]></article-title>
<source><![CDATA[J Clin Endocrinol Metab]]></source>
<year>2001</year>
<volume>86</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>2453-5</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ojeda-Ojeda]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mediators of low-grade chronic inflammation in polycystic ovary syndrome (PCOS)]]></article-title>
<source><![CDATA[Curr Pharm Des]]></source>
<year>2013</year>
<volume>19</volume>
<numero>32</numero>
<issue>32</issue>
<page-range>5775-91</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Spaczynski]]></surname>
<given-names><![CDATA[RZ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tumor necrosis factor-alpha stimulates proliferation of rat ovarian theca-interstitial cells]]></article-title>
<source><![CDATA[Biol Reprod]]></source>
<year>1999</year>
<volume>61</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>993-8</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hotamisligil]]></surname>
<given-names><![CDATA[GS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance]]></article-title>
<source><![CDATA[Science]]></source>
<year>1993</year>
<volume>259</volume>
<numero>5091</numero>
<issue>5091</issue>
<page-range>87-91</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moller]]></surname>
<given-names><![CDATA[DE.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes]]></article-title>
<source><![CDATA[Trends Endocrinol Metab]]></source>
<year>2000</year>
<volume>11</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>212-7</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alge]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Biomarkers of AKI: a review of mechanistic relevance and potential therapeutic implications]]></article-title>
<source><![CDATA[CJN]]></source>
<year>2014</year>
<numero>12191213</numero>
<issue>12191213</issue>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kluge]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mitochondria and endothelial function]]></article-title>
<source><![CDATA[Circ Res]]></source>
<year>2013</year>
<volume>112</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1171-88</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Incalza]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases]]></article-title>
<source><![CDATA[Vascul Pharmacol]]></source>
<year>2018</year>
<volume>100</volume>
<page-range>1-19</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Keane]]></surname>
<given-names><![CDATA[KN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Molecular events linking oxidative stress and inflammation to insulin resistance and beta-cell dysfunction]]></article-title>
<source><![CDATA[Oxid Med Cell Longev]]></source>
<year>2015</year>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Thathapudi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tumor necrosis factor-alpha and polycystic ovarian syndrome: a clinical, biochemical, and molecular genetic study]]></article-title>
<source><![CDATA[Genet Test Mol Biomarkers]]></source>
<year>2014</year>
<volume>18</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>605-9</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ihsan]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tumor necrosis factor-alpha and polycystic ovarian syndrome: a clinical, biochemical, and molecular genetic study]]></article-title>
<source><![CDATA[Genet Test Mol Biomarkers]]></source>
<year>2014</year>
<volume>18</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>605-9</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ihsan]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Significance of TNF-Alpha and Insulin Resistance in Women with Polycystic Ovarian Syndrome]]></article-title>
<source><![CDATA[PJMHS]]></source>
<year>2018</year>
<volume>12</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>459-63</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pawelczak]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluation of the pro-inflammatory cytokine tumor necrosis factor-alpha in adolescents with polycystic ovary syndrome]]></article-title>
<source><![CDATA[J Pediatr Adolesc Gynecol]]></source>
<year>2014</year>
<volume>27</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>356-9</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Artimani]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluation of pro-oxidant-antioxidant balance (PAB) and its association with inflammatory cytokines in polycystic ovary syndrome (PCOS)]]></article-title>
<source><![CDATA[Gynecol Endocrinol]]></source>
<year>2018</year>
<volume>34</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>148-52</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Is interleukin-18 associated with polycystic ovary syndrome?]]></article-title>
<source><![CDATA[Reproductive Biology and Endocrinology]]></source>
<year>2011</year>
<volume>9</volume>
<page-range>7</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Younis]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Serum tumor necrosis factor-alpha, interleukin-6, monocyte chemotactic protein-1 and paraoxonase-1 profiles in women with endometriosis, PCOS, or unexplained infertility]]></article-title>
<source><![CDATA[J Assist Reprod Genet]]></source>
<year>2014</year>
<volume>31</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1445-51</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Seyam]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tumor necrosis factor alpha versus LH and androstendione as a reliable predictor of spontaneous ovulation after laparoscopic ovarian drilling for women with clomiphene citrate resistance polycystic ovarian disease]]></article-title>
<source><![CDATA[Eur J Obstet Gynecol Reprod Biol]]></source>
<year>2018</year>
<volume>222</volume>
<page-range>126-33</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Artimani]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Follicular fluid concentrations of interleukin-6, Interleukin-8, TNF-[alpha] and interleukin 10 in polycystic ovarian syndrome women]]></article-title>
<source><![CDATA[Fertil and Steril]]></source>
<year>2015</year>
<volume>9</volume>
<numero>75</numero>
<issue>75</issue>
</nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Detection of dendritic cells and related cytokines in follicular fluid of patients with polycystic ovary syndrome]]></article-title>
<source><![CDATA[Am J Reprod Immunol]]></source>
<year>2017</year>
<volume>78</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Orostica]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Proinflammatory environment and role of TNF-alpha in endometrial function of obese women having polycystic ovarian syndrome]]></article-title>
<source><![CDATA[Int J Obes (Lond)]]></source>
<year>2016</year>
<volume>40</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1715-22</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chistyakova]]></surname>
<given-names><![CDATA[GN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Immunological and hemostasiological disorders in women with ovarian hyperstimulation syndrome]]></article-title>
<source><![CDATA[Gynecol Endocrinol]]></source>
<year>2014</year>
<volume>30</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>39-42</page-range></nlm-citation>
</ref>
<ref id="B34">
<label>34</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[JY]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Expression of the genes for peroxisome proliferator-activated receptor-&#947;, cyclooxygenase-2, and proinflammatory cytokines in granulosa cells from women with polycystic ovary syndrome]]></article-title>
<source><![CDATA[Clin Exp Reprod Med]]></source>
<year>2017</year>
<volume>44</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>146-51</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
